This review aims to provide clinicians with an updated and pragmatic guide to the use of genetic testing in inherited cardiovascular diseases, and addresses when genetic testing should be requested in cardiomyopathies and channelopathies, which genes should be tested across different conditions, and how genetic results...
F. Fortuni, A. Matteucci, F. Angelini et al.· Giornale italiano di cardiol...· 0 citations
Atrial fibrillation (AF) is increasingly understood as the electrical expression of a systemic and atrial cardiometabolic disease rather than an isolated disorder of pulmonary-vein triggers. Obesity, insulin resistance, hypertension, sleep-disordered breathing, heart failure with preserved ejection fraction, and viscer...
A. Matteucci, M. Bonanni, Luca Sgarra et al.· Journal of Cardiovascular De...· 0 citations
BACKGROUND
Nonstatin low-density lipoprotein (LDL)-cholesterol-lowering therapies are increasingly used in secondary prevention, familial hypercholesterolemia, and statin-intolerant patients, but adverse-event reporting is heterogeneous, and harmonized safety evidence remains limited.
OBJECTIVE
To evaluate the tolera...
A. Matteucci, M. Bonanni, S. D. Di Fusco et al.· Journal of Clinical Lipidolo...· 0 citations
Overall, current evidence supports the technical efficacy of the WCD for terminating sustained ventricular tachyarrhythmias, but observational shock rates do not establish a population-level survival benefit.
A. Matteucci, M. Bonanni, M. Mariani et al.· Diagnostics· 0 citations
Findings should be interpreted cautiously and viewed as consistent with, rather than definitive evidence of, an association between particulate exposure and arrhythmia-related events.
A. Matteucci, Luca Sgarra, M. Bonanni et al.· Heart Rhythm· 1 citation· ⚡1
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.